New Method Safely Inserts Gene-Sized DNA Into Genome

Researchers develop a non-toxic approach for inserting large genetic payloads into cells.

Mar. 12, 2026 at 3:05am

Got story updates? Submit your updates here. ›

Researchers from Mass General Brigham have developed a novel method called INSTALL that can safely insert gene-sized DNA sequences into the human genome without triggering dangerous immune responses. The approach uses single-stranded DNA circles and engineered recombinase enzymes to enable large-scale genome writing, overcoming limitations of previous methods that relied on double-stranded DNA or viral vectors.

Why it matters

Most genetic disorders are caused by numerous unique mutations, making it challenging to develop customized therapies for individual patients. The INSTALL method offers a more universal strategy by allowing the precise insertion of an entire healthy gene copy, which could provide a single treatment applicable to all patients with that genetic condition.

The details

The researchers recognized that single-stranded DNA circles could evade immune detection, but recombinase enzymes evolved to work with double-stranded DNA. By studying how bacteria and viruses insert single-stranded DNA, the team designed a hybrid approach using a DNA circle with a short double-stranded region to enable recombinase compatibility while maintaining immune evasion. This INSTALL method demonstrated successful and safe large DNA integration in human cells and mouse livers, in contrast to the toxicity seen with conventional double-stranded DNA approaches.

  • The study was published on March 12, 2026 in the journal Nature.

The players

Benjamin P. Kleinstiver

Senior author of the study, Kayden-Lambert MGH Research Scholar and associate investigator in the Center for Genomic Medicine at Mass General Brigham.

Connor Tou

Lead author of the study, a postdoctoral fellow in the Kleinstiver lab.

Howard Wu

Key contributor from Full Circles Therapeutics, a company that manufactures circular single-stranded DNA and develops DNA-based non-viral genomic medicines.

Keqiang Xie

Key contributor from Full Circles Therapeutics.

Patricia Musolino

Researcher from the Mass General Brigham Center for Genomic Medicine who helped lead DNA integration and immunology studies in mice.

Got photos? Submit your photos here. ›

What they’re saying

“Overall, this study demonstrates that large-scale genome writing is now possible without triggering dangerous immune responses and can be done independently of viral vectors.”

— Benjamin P. Kleinstiver, Senior author (Mirage News)

“This was an exciting realization. We then wondered whether these mechanisms could be recapitulated in human cells, hoping to solve the innate immunity challenge that has impeded efficient gene insertion.”

— Connor Tou, Lead author (Mirage News)

“One of the most exciting moments of this study was seeing the stark differences in how well the mice responded to INSTALL compared with the toxicity of dsDNA. When the INSTALL-treated mice looked similar to untreated controls, we knew this could be a game changer.”

— Connor Tou, Lead author (Mirage News)

What’s next

The authors are optimistic that continued efforts to improve the DNA cargo and recombinase enzyme engineering will result in substantial advances in large sequence insertion technologies in the near future.

The takeaway

The INSTALL method represents a significant breakthrough in genome editing, enabling the safe and precise insertion of entire gene-sized DNA sequences into the human genome without triggering dangerous immune responses. This could pave the way for more effective and widely applicable genetic therapies to treat a variety of inherited disorders.